{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T22:26:40Z","timestamp":1770416800073,"version":"3.49.0"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T00:00:00Z","timestamp":1536537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1,1]]},"DOI":"10.1093\/rheumatology\/key263","type":"journal-article","created":{"date-parts":[[2018,7,29]],"date-time":"2018-07-29T07:07:05Z","timestamp":1532848025000},"page":"149-153","source":"Crossref","is-referenced-by-count":16,"title":["Autoantibody status is not associated with early treatment response to first-line methotrexate in patients with early rheumatoid arthritis"],"prefix":"10.1093","volume":"58","author":[{"given":"Jacqueline S","family":"Dekkers","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7136-5248","authenticated-orcid":false,"given":"Sytske Anne","family":"Bergstra","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands"}]},{"given":"Arvind","family":"Chopra","sequence":"additional","affiliation":[{"name":"Department of Rheumatic Diseases, Pune, India"}]},{"given":"Mohammed","family":"Tikly","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University of Witwatersrand, Johannesburg, South Africa"}]},{"given":"Jo\u00e3o Eurico","family":"Fonseca","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Lisbon Academic Medical Centre, Lisbon, Portugal"}]},{"given":"Karen","family":"Salomon-Escoto","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, UMass Memorial Medical Center, Central Massachusetts, MA, USA"}]},{"given":"Tom W J","family":"Huizinga","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands"}]},{"given":"Diane","family":"van der Woude","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands"}]}],"member":"286","published-online":{"date-parts":[[2018,9,10]]},"reference":[{"key":"key\n\t\t\t\t2018121406541904100_key263-B1","doi-asserted-by":"crossref","first-page":"R949","DOI":"10.1186\/ar1767","article-title":"Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis","volume":"7","author":"van der Helm-van Mil","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"key\n\t\t\t\t2018121406541904100_key263-B2","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1136\/ard.2003.014233","article-title":"Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP)","volume":"63","author":"Forslind","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2018121406541904100_key263-B3","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1136\/ard.2004.033571","article-title":"Longitudinal analysis of citrullinated protein\/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression","volume":"64","author":"R\u00f6nnelid","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2018121406541904100_key263-B4","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/annrheumdis-2011-201117","article-title":"Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis","volume":"72","author":"Isaacs","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2018121406541904100_key263-B5","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1002\/art.39595","article-title":"Brief report: association of rheumatoid factor and anti-citrullinated protein antibody positivity with better effectiveness of abatacept: results from the Pan-European Registry Analysis","volume":"68","author":"Gottenberg","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"key\n\t\t\t\t2018121406541904100_key263-B6","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/ard.2009.126532","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs","volume":"69","author":"Smolen","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2018121406541904100_key263-B7","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/acr.20188","article-title":"Predictors for remission in rheumatoid arthritis patients: a systematic review","volume":"62","author":"Katchamart","year":"2010","journal-title":"Arthritis Care Res"},{"key":"key\n\t\t\t\t2018121406541904100_key263-B8","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/rheumatology\/38.3.228","article-title":"Does the age of onset of rheumatoid arthritis influence phenotype? A prospective study of outcome and prognostic factors","volume":"38","author":"Pease","year":"1999","journal-title":"Rheumatology"},{"key":"key\n\t\t\t\t2018121406541904100_key263-B9","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/ard.2003.014928","article-title":"A good response to early DMARD treatment of patients with rheumatoid arthritis in the first year predicts remission during follow up","volume":"64","author":"Verstappen","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2018121406541904100_key263-B10","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1002\/art.22525","article-title":"Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial","volume":"56","author":"van Dongen","year":"2007","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t2018121406541904100_key263-B11","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.3899\/jrheum.140082","article-title":"Prognosis of seronegative patients in a large prospective cohort of patients with early inflammatory arthritis","volume":"41","author":"Barra","year":"2014","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t2018121406541904100_key263-B12","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.3899\/jrheum.140137","article-title":"Earlier time to remission predicts sustained clinical remission in early rheumatoid arthritis\u2014results from the Canadian Early Arthritis Cohort (CATCH)","volume":"41","author":"Kuriya","year":"2014","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t2018121406541904100_key263-B13","first-page":"S-135","article-title":"The METEOR initiative: the way forward for optimal, worldwide data integration to improve care for RA patients","volume":"32(5 Suppl 85)","author":"van den Berg","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"key\n\t\t\t\t2018121406541904100_key263-B14","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1198\/000313001317098266","article-title":"Multiple imputation in practice","volume":"55","author":"Horton","year":"2001","journal-title":"Am Stat"},{"key":"key\n\t\t\t\t2018121406541904100_key263-B15","first-page":"2016","article-title":"Minimal disease activity for rheumatoid arthritis: a preliminary definition","volume":"32","author":"Wells","year":"2005","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t2018121406541904100_key263-B16","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1136\/ard.2008.088070","article-title":"Pretreatment serum levels of anti-cyclic citrullinated peptide antibodies are associated with the response to methotrexate in recent-onset arthritis","volume":"67","author":"Visser","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2018121406541904100_key263-B17","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1136\/annrheumdis-2011-200736","article-title":"Remission induction therapy with methotrexate and prednisone in patients with early rheumatoid and undifferentiated arthritis (the IMPROVED study)","volume":"71","author":"Wevers-de Boer","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2018121406541904100_key263-B18","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.3899\/jrheum.091452","article-title":"Rheumatoid arthritis in a North American native population: longitudinal followup and comparison with a white population","volume":"37","author":"Peschken","year":"2010","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t2018121406541904100_key263-B19","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/ard.2009.120899","article-title":"Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke","volume":"70","author":"Kallberg","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t2018121406541904100_key263-B20","volume-title":"The Tobacco Atlas","author":"Drope","year":"2018"},{"key":"key\n\t\t\t\t2018121406541904100_key263-B21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4103\/0971-5851.103139","article-title":"An overview of the tobacco problem in India","volume":"33","author":"Mishra","year":"2012","journal-title":"Indian J Med Paediatr Oncol"},{"key":"key\n\t\t\t\t2018121406541904100_key263-B22","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nrrheum.2017.15","article-title":"Beyond citrullination: other post-translational protein modifications in rheumatoid arthritis","volume":"13","author":"Trouw","year":"2017","journal-title":"Nat Rev Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/58\/1\/149\/27145394\/key263.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T08:25:39Z","timestamp":1571646339000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/58\/1\/149\/5094544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,10]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,9,10]]},"published-print":{"date-parts":[[2019,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/key263","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,1]]},"published":{"date-parts":[[2018,9,10]]}}}